This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Individuals, company fined for obstructing pharma probe in China's Sichuan

By MLex Staff ( May 26, 2025, 07:58 GMT | Insight) -- Six individuals and one company have been fined for obstructing an on-site antitrust investigation in Sichuan, a southwestern province of China, reflecting the tougher penalties imposed on both individuals and companies since the antitrust law was revised in 2022. Recent penalty decisions by local authorities have emphasized personal liability in antitrust enforcement, particularly in the pharmaceutical industry, a sector close to people’s livelihoods.Six individuals and one company have been fined for obstructing an on-site antitrust investigation in Sichuan, a southwestern province of China, reflecting the tougher penalties imposed on both individuals and companies since the antitrust law was revised in 2022....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections